MARKET WIRE NEWS

Buy Recommendation Issued On BHVN By Goldman Sachs

Source: KlickAnalytics

2026-02-05 16:15:03 ET

  • Goldman Sachs analyst issues BUY recommendation for BHVN on February 5, 2026 09:18PM ET.
  • BHVN was trading at $10.76 at issue of the analyst recommendation.
  • The overall analyst consensus : BUY.
  • Current analyst recommendations are : 18 - Buy, 7 - Hold recommendations .

  • Historical Analyst Recommendations
    Latest 10 recommendations
    Report D ...
    Full story available on KlickAnalytics.com
    Biohaven Pharmaceutical Holding Company Ltd.

    NASDAQ: BHVN

    BHVN Trading

    -2.46% G/L:

    $9.90 Last:

    912,901 Volume:

    $10.05 Open:

    mwn-alerts Ad 300

    BHVN Latest News

    BHVN Stock Data

    $1,610,213,046
    113,271,989
    1.64%
    9
    N/A
    Biotechnology & Life Sciences
    Healthcare
    US
    New Haven

    Subscribe to Our Newsletter

    Link Market Wire News to Your X Account

    Download The Market Wire News App